Hypothesis

Peripheral monocytes that undergo trained immunity (e.g., beta‑glucan priming) release soluble factors that, during the low‑norepinephrine window of slow‑wave sleep, enhance astrocytic AQP4 polarization and perivascular CSF influx, thereby accelerating extracellular waste clearance. Conversely, sleep deprivation blocks this monocyte‑to‑astrocyte signaling, turning trained immunity into a liability that exacerbates proteostatic stress.

Mechanistic Rationale

• Trained monocytes exhibit heightened IL‑33 and GM‑CSF secretion after beta‑glucan exposure [4].
• IL‑33 can act on astrocytic IL‑1R1/ST2 receptors to trigger HIF‑1α stabilization and transcriptional up‑regulation of AQP4, a process that is suppressed by high catecholamine tone during wakefulness.
• During slow‑wave sleep, norepinephrine drops >90 %, expanding interstitial space and permitting IL‑33/GM‑CSF to diffuse to perivascular astrocytic endfeet without vascular contraction [1].
• Elevated AQP4 increases hydraulic conductivity of the glymphatic conduit, speeding CSF‑interstitial fluid exchange and facilitating clearance of amyloid‑beta, tau, and microglial lipid debris.
• In aged brains, myelin‑derived lipofuscin overloads microglia [3]; trained‑immune monocytes may compensate by shuttling lipids via exosomes to astrocytes for lysosomal processing, a step that requires completed autophagic flux during sleep [2].

Testable Predictions

1. In young adult mice, systemic beta‑glucan administration will increase CSF influx tracer (e.g., Evans blue‑albumin) during subsequent NREM sleep by ~30 % compared with saline controls, measurable by in‑vivo two‑photon microscopy; this enhancement will be absent in mice subjected to 6 h of sleep deprivation prior to tracer injection.
2. Pharmacological blockade of IL‑33 signaling (anti‑ST2 antibody) or astrocytic HIF‑1α deletion will abolish the beta‑glucan‑induced boost in glymphatic flow without affecting baseline sleep‑linked clearance.
3. CCR2‑deficient mice, which impede monocyte brain entry, will show no sleep‑dependent improvement in amyloid‑beta clearance after beta‑glucan training, whereas wild‑type counterparts will display reduced plaque load after repeated sleep cycles.
4. Aged mice with fragmented myelin will exhibit a inverted U‑response: low‑dose beta‑glucan improves sleep‑linked glymphatic flux, but high‑dose leads to excess proinflammatory cytokine spillover that disrupts slow‑wave activity, detectable by EEG power suppression in the 0.5‑4 Hz band.

Potential Caveats

• Peripheral trained immunity may also alter vascular tone independently of sleep; controlling for blood pressure changes is essential.
• The glymphatic tracer assays must differentiate between increased influx versus reduced efflux to avoid misattribution.
• Species differences in monocyte‑brain trafficking could limit translational relevance; validation in human CSF biomarker studies (e.g., IL‑33, AQP4 polarity via PET) is required.

This framework links immune metabolic programming to the brain’s nightly autoclearance, positioning sleep not merely as a passive cleanup but as a conditional gate that decides whether trained immunity sustains neural homeostasis or tips it toward degeneration.